Stage II Adult Soft Tissue Sarcoma

8 clinical trials · Condition

Record	Firm	Date
Fluorothymidine F-18 PET in Diagnosing Patients With Intermediate or High Grade Soft Tissue Sarcoma (NCT03613259)	OHSU Knight Cancer Institute	2020-06-01
18F-Fluoromisonidazole and Fludeoxyglucose F 18 PET/CT Patients With Soft Tissue Sarcoma (NCT01169350)	National Cancer Institute (NCI)	2010-02-01
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma (NCT00346164)	Children's Oncology Group	2007-02-05
Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07) (NCT00330421)	National Cancer Institute (NCI)	2006-06-01
CCI-779 in Treating Patients With Soft Tissue Sarcoma or Gastrointestinal Stromal Tumor (NCT00087074)	National Cancer Institute (NCI)	2004-06-01
EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer (NCT00087191)	National Cancer Institute (NCI)	2004-05-01
Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma (NCT00003958)	Children's Oncology Group	2002-09-01
EF5 to Evaluate Tumor Hypoxia in Patients With High-Grade Soft Tissue Sarcoma or Mouth Cancer (NCT00896961)	National Cancer Institute (NCI)	2001-08-01

Every clearance here is in the API, with alerts when new ones post.